Fan et al. found that the interaction between ALDOC and the C-terminal of MUC16 enhanced the growth of gallbladder cancer, primarily by disrupting glucose sensing and activating associated metabolic pathways, thereby reshaping the tumor microenvironment and further reinforcing ALDOC's pro-carcinogenic role in glycolysis 222. Here, ALDOC is linked to gallbladder cancer.